nodes	percent_of_prediction	percent_of_DWPC	metapath
Mannitol—ABCB1—kidney cancer	0.386	1	CbGaD
Mannitol—ABCB1—Temsirolimus—kidney cancer	0.0945	0.225	CbGbCtD
Mannitol—ABCB1—Pazopanib—kidney cancer	0.0496	0.118	CbGbCtD
Mannitol—ABCB1—Dactinomycin—kidney cancer	0.0454	0.108	CbGbCtD
Mannitol—ABCB1—Gemcitabine—kidney cancer	0.0359	0.0856	CbGbCtD
Mannitol—ABCB1—Erlotinib—kidney cancer	0.0354	0.0845	CbGbCtD
Mannitol—ABCB1—Paclitaxel—kidney cancer	0.0324	0.0773	CbGbCtD
Mannitol—ABCB1—Sorafenib—kidney cancer	0.0288	0.0687	CbGbCtD
Mannitol—ABCB1—Vinblastine—kidney cancer	0.0284	0.0678	CbGbCtD
Mannitol—ABCB1—Vincristine—kidney cancer	0.028	0.0667	CbGbCtD
Mannitol—ABCB1—Sunitinib—kidney cancer	0.0233	0.0557	CbGbCtD
Mannitol—ABCB1—Doxorubicin—kidney cancer	0.0175	0.0417	CbGbCtD
Mannitol—Phlebitis—Doxorubicin—kidney cancer	0.000143	0.000737	CcSEcCtD
Mannitol—Arthralgia—Gemcitabine—kidney cancer	0.000143	0.000735	CcSEcCtD
Mannitol—Chest pain—Gemcitabine—kidney cancer	0.000143	0.000735	CcSEcCtD
Mannitol—Thrombophlebitis—Doxorubicin—kidney cancer	0.000143	0.000733	CcSEcCtD
Mannitol—Diabetes mellitus—Doxorubicin—kidney cancer	0.000142	0.00073	CcSEcCtD
Mannitol—Blood alkaline phosphatase increased—Doxorubicin—kidney cancer	0.000142	0.00073	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—kidney cancer	0.000142	0.00073	CcSEcCtD
Mannitol—Nervous system disorder—Vincristine—kidney cancer	0.000142	0.000728	CcSEcCtD
Mannitol—Asthenia—Erlotinib—kidney cancer	0.000142	0.000727	CcSEcCtD
Mannitol—Mental disorder—Paclitaxel—kidney cancer	0.000142	0.000727	CcSEcCtD
Mannitol—Discomfort—Gemcitabine—kidney cancer	0.000141	0.000726	CcSEcCtD
Mannitol—Urticaria—Sorafenib—kidney cancer	0.000141	0.000725	CcSEcCtD
Mannitol—Malnutrition—Paclitaxel—kidney cancer	0.000141	0.000722	CcSEcCtD
Mannitol—Decreased appetite—Dactinomycin—kidney cancer	0.000141	0.000722	CcSEcCtD
Mannitol—Diarrhoea—Vinblastine—kidney cancer	0.000141	0.000722	CcSEcCtD
Mannitol—Body temperature increased—Sorafenib—kidney cancer	0.00014	0.000721	CcSEcCtD
Mannitol—Diarrhoea—Everolimus—kidney cancer	0.00014	0.000719	CcSEcCtD
Mannitol—Pruritus—Erlotinib—kidney cancer	0.00014	0.000717	CcSEcCtD
Mannitol—Fatigue—Dactinomycin—kidney cancer	0.000139	0.000716	CcSEcCtD
Mannitol—Flatulence—Paclitaxel—kidney cancer	0.000139	0.000712	CcSEcCtD
Mannitol—Pain—Dactinomycin—kidney cancer	0.000138	0.00071	CcSEcCtD
Mannitol—Oedema—Gemcitabine—kidney cancer	0.000137	0.000704	CcSEcCtD
Mannitol—Nervousness—Paclitaxel—kidney cancer	0.000137	0.000702	CcSEcCtD
Mannitol—Cardiac failure congestive—Doxorubicin—kidney cancer	0.000136	0.0007	CcSEcCtD
Mannitol—Infection—Gemcitabine—kidney cancer	0.000136	0.0007	CcSEcCtD
Mannitol—Back pain—Paclitaxel—kidney cancer	0.000136	0.000699	CcSEcCtD
Mannitol—Dizziness—Vinblastine—kidney cancer	0.000136	0.000697	CcSEcCtD
Mannitol—Dizziness—Everolimus—kidney cancer	0.000135	0.000695	CcSEcCtD
Mannitol—Body temperature increased—Sunitinib—kidney cancer	0.000135	0.000694	CcSEcCtD
Mannitol—Diarrhoea—Erlotinib—kidney cancer	0.000135	0.000694	CcSEcCtD
Mannitol—Hypotension—Vincristine—kidney cancer	0.000135	0.000694	CcSEcCtD
Mannitol—Nervous system disorder—Gemcitabine—kidney cancer	0.000134	0.000691	CcSEcCtD
Mannitol—Feeling abnormal—Dactinomycin—kidney cancer	0.000133	0.000685	CcSEcCtD
Mannitol—Skin disorder—Gemcitabine—kidney cancer	0.000133	0.000684	CcSEcCtD
Mannitol—Rhinitis—Capecitabine—kidney cancer	0.000133	0.000683	CcSEcCtD
Mannitol—Vision blurred—Paclitaxel—kidney cancer	0.000133	0.000681	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Vincristine—kidney cancer	0.000132	0.000676	CcSEcCtD
Mannitol—Pharyngitis—Capecitabine—kidney cancer	0.000132	0.000676	CcSEcCtD
Mannitol—Urinary tract disorder—Capecitabine—kidney cancer	0.000131	0.000673	CcSEcCtD
Mannitol—Hypersensitivity—Sorafenib—kidney cancer	0.000131	0.000672	CcSEcCtD
Mannitol—Vomiting—Vinblastine—kidney cancer	0.000131	0.000671	CcSEcCtD
Mannitol—Dizziness—Erlotinib—kidney cancer	0.000131	0.00067	CcSEcCtD
Mannitol—Ill-defined disorder—Paclitaxel—kidney cancer	0.000131	0.00067	CcSEcCtD
Mannitol—Connective tissue disorder—Capecitabine—kidney cancer	0.00013	0.000669	CcSEcCtD
Mannitol—Vomiting—Everolimus—kidney cancer	0.00013	0.000668	CcSEcCtD
Mannitol—Urethral disorder—Capecitabine—kidney cancer	0.00013	0.000668	CcSEcCtD
Mannitol—Rash—Everolimus—kidney cancer	0.000129	0.000662	CcSEcCtD
Mannitol—Dermatitis—Everolimus—kidney cancer	0.000129	0.000662	CcSEcCtD
Mannitol—Headache—Vinblastine—kidney cancer	0.000129	0.000661	CcSEcCtD
Mannitol—Headache—Everolimus—kidney cancer	0.000128	0.000658	CcSEcCtD
Mannitol—Hypotension—Gemcitabine—kidney cancer	0.000128	0.000658	CcSEcCtD
Mannitol—Body temperature increased—Dactinomycin—kidney cancer	0.000128	0.000657	CcSEcCtD
Mannitol—Asthenia—Sorafenib—kidney cancer	0.000127	0.000654	CcSEcCtD
Mannitol—Malaise—Paclitaxel—kidney cancer	0.000127	0.000651	CcSEcCtD
Mannitol—Cardiac failure—Doxorubicin—kidney cancer	0.000127	0.00065	CcSEcCtD
Mannitol—Vertigo—Paclitaxel—kidney cancer	0.000126	0.000649	CcSEcCtD
Mannitol—Hypersensitivity—Sunitinib—kidney cancer	0.000126	0.000647	CcSEcCtD
Mannitol—Decreased appetite—Vincristine—kidney cancer	0.000126	0.000645	CcSEcCtD
Mannitol—Pruritus—Sorafenib—kidney cancer	0.000126	0.000645	CcSEcCtD
Mannitol—Vomiting—Erlotinib—kidney cancer	0.000126	0.000645	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000125	0.000642	CcSEcCtD
Mannitol—Gastrointestinal disorder—Vincristine—kidney cancer	0.000125	0.000641	CcSEcCtD
Mannitol—Fatigue—Vincristine—kidney cancer	0.000125	0.00064	CcSEcCtD
Mannitol—Rash—Erlotinib—kidney cancer	0.000124	0.000639	CcSEcCtD
Mannitol—Dermatitis—Erlotinib—kidney cancer	0.000124	0.000639	CcSEcCtD
Mannitol—Hyponatraemia—Doxorubicin—kidney cancer	0.000124	0.000637	CcSEcCtD
Mannitol—Headache—Erlotinib—kidney cancer	0.000124	0.000635	CcSEcCtD
Mannitol—Pain—Vincristine—kidney cancer	0.000124	0.000635	CcSEcCtD
Mannitol—Pain in extremity—Doxorubicin—kidney cancer	0.000124	0.000635	CcSEcCtD
Mannitol—Cough—Paclitaxel—kidney cancer	0.000123	0.00063	CcSEcCtD
Mannitol—Asthenia—Sunitinib—kidney cancer	0.000123	0.00063	CcSEcCtD
Mannitol—Dyspnoea—Gemcitabine—kidney cancer	0.000122	0.000628	CcSEcCtD
Mannitol—Nausea—Vinblastine—kidney cancer	0.000122	0.000627	CcSEcCtD
Mannitol—Convulsion—Paclitaxel—kidney cancer	0.000122	0.000626	CcSEcCtD
Mannitol—Nausea—Everolimus—kidney cancer	0.000122	0.000624	CcSEcCtD
Mannitol—Diarrhoea—Sorafenib—kidney cancer	0.000122	0.000624	CcSEcCtD
Mannitol—Hypertension—Paclitaxel—kidney cancer	0.000121	0.000624	CcSEcCtD
Mannitol—Pruritus—Sunitinib—kidney cancer	0.000121	0.000621	CcSEcCtD
Mannitol—Arthralgia—Paclitaxel—kidney cancer	0.00012	0.000615	CcSEcCtD
Mannitol—Chest pain—Paclitaxel—kidney cancer	0.00012	0.000615	CcSEcCtD
Mannitol—Mediastinal disorder—Capecitabine—kidney cancer	0.00012	0.000614	CcSEcCtD
Mannitol—Decreased appetite—Gemcitabine—kidney cancer	0.000119	0.000612	CcSEcCtD
Mannitol—Hypersensitivity—Dactinomycin—kidney cancer	0.000119	0.000612	CcSEcCtD
Mannitol—Chills—Capecitabine—kidney cancer	0.000119	0.000611	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	0.000119	0.000611	CcSEcCtD
Mannitol—Gastrointestinal disorder—Gemcitabine—kidney cancer	0.000118	0.000608	CcSEcCtD
Mannitol—Discomfort—Paclitaxel—kidney cancer	0.000118	0.000608	CcSEcCtD
Mannitol—Fatigue—Gemcitabine—kidney cancer	0.000118	0.000607	CcSEcCtD
Mannitol—Dizziness—Sorafenib—kidney cancer	0.000117	0.000603	CcSEcCtD
Mannitol—Pain—Gemcitabine—kidney cancer	0.000117	0.000602	CcSEcCtD
Mannitol—Nausea—Erlotinib—kidney cancer	0.000117	0.000602	CcSEcCtD
Mannitol—Diarrhoea—Sunitinib—kidney cancer	0.000117	0.0006	CcSEcCtD
Mannitol—Mental disorder—Capecitabine—kidney cancer	0.000116	0.000597	CcSEcCtD
Mannitol—Asthenia—Dactinomycin—kidney cancer	0.000116	0.000596	CcSEcCtD
Mannitol—Malnutrition—Capecitabine—kidney cancer	0.000115	0.000593	CcSEcCtD
Mannitol—Dehydration—Doxorubicin—kidney cancer	0.000115	0.00059	CcSEcCtD
Mannitol—Oedema—Paclitaxel—kidney cancer	0.000115	0.00059	CcSEcCtD
Mannitol—Body temperature increased—Vincristine—kidney cancer	0.000114	0.000587	CcSEcCtD
Mannitol—Infection—Paclitaxel—kidney cancer	0.000114	0.000586	CcSEcCtD
Mannitol—Flatulence—Capecitabine—kidney cancer	0.000114	0.000584	CcSEcCtD
Mannitol—Dizziness—Sunitinib—kidney cancer	0.000113	0.00058	CcSEcCtD
Mannitol—Feeling abnormal—Gemcitabine—kidney cancer	0.000113	0.00058	CcSEcCtD
Mannitol—Vomiting—Sorafenib—kidney cancer	0.000113	0.00058	CcSEcCtD
Mannitol—Abdominal pain upper—Doxorubicin—kidney cancer	0.000113	0.00058	CcSEcCtD
Mannitol—Nervous system disorder—Paclitaxel—kidney cancer	0.000113	0.000578	CcSEcCtD
Mannitol—Tachycardia—Paclitaxel—kidney cancer	0.000112	0.000575	CcSEcCtD
Mannitol—Rash—Sorafenib—kidney cancer	0.000112	0.000575	CcSEcCtD
Mannitol—Dermatitis—Sorafenib—kidney cancer	0.000112	0.000575	CcSEcCtD
Mannitol—Back pain—Capecitabine—kidney cancer	0.000112	0.000573	CcSEcCtD
Mannitol—Skin disorder—Paclitaxel—kidney cancer	0.000112	0.000573	CcSEcCtD
Mannitol—Headache—Sorafenib—kidney cancer	0.000111	0.000571	CcSEcCtD
Mannitol—Diarrhoea—Dactinomycin—kidney cancer	0.000111	0.000568	CcSEcCtD
Mannitol—Nasopharyngitis—Doxorubicin—kidney cancer	0.00011	0.000567	CcSEcCtD
Mannitol—Vision blurred—Capecitabine—kidney cancer	0.000109	0.000559	CcSEcCtD
Mannitol—Vomiting—Sunitinib—kidney cancer	0.000109	0.000558	CcSEcCtD
Mannitol—Body temperature increased—Gemcitabine—kidney cancer	0.000108	0.000557	CcSEcCtD
Mannitol—Rash—Sunitinib—kidney cancer	0.000108	0.000553	CcSEcCtD
Mannitol—Dermatitis—Sunitinib—kidney cancer	0.000108	0.000553	CcSEcCtD
Mannitol—Hypotension—Paclitaxel—kidney cancer	0.000107	0.000551	CcSEcCtD
Mannitol—Ill-defined disorder—Capecitabine—kidney cancer	0.000107	0.00055	CcSEcCtD
Mannitol—Headache—Sunitinib—kidney cancer	0.000107	0.00055	CcSEcCtD
Mannitol—Hypersensitivity—Vincristine—kidney cancer	0.000106	0.000547	CcSEcCtD
Mannitol—Nausea—Sorafenib—kidney cancer	0.000105	0.000542	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000105	0.000537	CcSEcCtD
Mannitol—Malaise—Capecitabine—kidney cancer	0.000104	0.000535	CcSEcCtD
Mannitol—Angina pectoris—Doxorubicin—kidney cancer	0.000104	0.000534	CcSEcCtD
Mannitol—Vertigo—Capecitabine—kidney cancer	0.000104	0.000533	CcSEcCtD
Mannitol—Asthenia—Vincristine—kidney cancer	0.000104	0.000533	CcSEcCtD
Mannitol—Vomiting—Dactinomycin—kidney cancer	0.000103	0.000528	CcSEcCtD
Mannitol—Bronchitis—Doxorubicin—kidney cancer	0.000103	0.000527	CcSEcCtD
Mannitol—Dyspnoea—Paclitaxel—kidney cancer	0.000102	0.000526	CcSEcCtD
Mannitol—Rash—Dactinomycin—kidney cancer	0.000102	0.000524	CcSEcCtD
Mannitol—Nausea—Sunitinib—kidney cancer	0.000101	0.000521	CcSEcCtD
Mannitol—Cough—Capecitabine—kidney cancer	0.000101	0.000517	CcSEcCtD
Mannitol—Decreased appetite—Paclitaxel—kidney cancer	9.98e-05	0.000513	CcSEcCtD
Mannitol—Hypertension—Capecitabine—kidney cancer	9.97e-05	0.000512	CcSEcCtD
Mannitol—Upper respiratory tract infection—Doxorubicin—kidney cancer	9.92e-05	0.00051	CcSEcCtD
Mannitol—Gastrointestinal disorder—Paclitaxel—kidney cancer	9.91e-05	0.000509	CcSEcCtD
Mannitol—Fatigue—Paclitaxel—kidney cancer	9.9e-05	0.000508	CcSEcCtD
Mannitol—Diarrhoea—Vincristine—kidney cancer	9.89e-05	0.000508	CcSEcCtD
Mannitol—Asthenia—Gemcitabine—kidney cancer	9.84e-05	0.000505	CcSEcCtD
Mannitol—Arthralgia—Capecitabine—kidney cancer	9.83e-05	0.000505	CcSEcCtD
Mannitol—Chest pain—Capecitabine—kidney cancer	9.83e-05	0.000505	CcSEcCtD
Mannitol—Pain—Paclitaxel—kidney cancer	9.82e-05	0.000504	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	9.76e-05	0.000501	CcSEcCtD
Mannitol—Discomfort—Capecitabine—kidney cancer	9.71e-05	0.000499	CcSEcCtD
Mannitol—Pruritus—Gemcitabine—kidney cancer	9.7e-05	0.000498	CcSEcCtD
Mannitol—Nausea—Dactinomycin—kidney cancer	9.61e-05	0.000494	CcSEcCtD
Mannitol—Dizziness—Vincristine—kidney cancer	9.56e-05	0.000491	CcSEcCtD
Mannitol—Infestation—Doxorubicin—kidney cancer	9.52e-05	0.000489	CcSEcCtD
Mannitol—Infestation NOS—Doxorubicin—kidney cancer	9.52e-05	0.000489	CcSEcCtD
Mannitol—Feeling abnormal—Paclitaxel—kidney cancer	9.46e-05	0.000486	CcSEcCtD
Mannitol—Oedema—Capecitabine—kidney cancer	9.42e-05	0.000484	CcSEcCtD
Mannitol—Diarrhoea—Gemcitabine—kidney cancer	9.38e-05	0.000482	CcSEcCtD
Mannitol—Renal failure—Doxorubicin—kidney cancer	9.36e-05	0.000481	CcSEcCtD
Mannitol—Infection—Capecitabine—kidney cancer	9.36e-05	0.000481	CcSEcCtD
Mannitol—Stomatitis—Doxorubicin—kidney cancer	9.28e-05	0.000477	CcSEcCtD
Mannitol—Nervous system disorder—Capecitabine—kidney cancer	9.24e-05	0.000474	CcSEcCtD
Mannitol—Tachycardia—Capecitabine—kidney cancer	9.19e-05	0.000472	CcSEcCtD
Mannitol—Vomiting—Vincristine—kidney cancer	9.19e-05	0.000472	CcSEcCtD
Mannitol—Skin disorder—Capecitabine—kidney cancer	9.15e-05	0.00047	CcSEcCtD
Mannitol—Urticaria—Paclitaxel—kidney cancer	9.12e-05	0.000468	CcSEcCtD
Mannitol—Rash—Vincristine—kidney cancer	9.11e-05	0.000468	CcSEcCtD
Mannitol—Dermatitis—Vincristine—kidney cancer	9.1e-05	0.000468	CcSEcCtD
Mannitol—Body temperature increased—Paclitaxel—kidney cancer	9.07e-05	0.000466	CcSEcCtD
Mannitol—Headache—Vincristine—kidney cancer	9.05e-05	0.000465	CcSEcCtD
Mannitol—Hypotension—Capecitabine—kidney cancer	8.8e-05	0.000452	CcSEcCtD
Mannitol—Vomiting—Gemcitabine—kidney cancer	8.72e-05	0.000448	CcSEcCtD
Mannitol—Rash—Gemcitabine—kidney cancer	8.65e-05	0.000444	CcSEcCtD
Mannitol—Dermatitis—Gemcitabine—kidney cancer	8.64e-05	0.000444	CcSEcCtD
Mannitol—Headache—Gemcitabine—kidney cancer	8.59e-05	0.000441	CcSEcCtD
Mannitol—Nausea—Vincristine—kidney cancer	8.58e-05	0.000441	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Capecitabine—kidney cancer	8.58e-05	0.000441	CcSEcCtD
Mannitol—Rhinitis—Doxorubicin—kidney cancer	8.57e-05	0.00044	CcSEcCtD
Mannitol—Pharyngitis—Doxorubicin—kidney cancer	8.48e-05	0.000436	CcSEcCtD
Mannitol—Hypersensitivity—Paclitaxel—kidney cancer	8.46e-05	0.000434	CcSEcCtD
Mannitol—Urinary tract disorder—Doxorubicin—kidney cancer	8.44e-05	0.000434	CcSEcCtD
Mannitol—Connective tissue disorder—Doxorubicin—kidney cancer	8.4e-05	0.000431	CcSEcCtD
Mannitol—Dyspnoea—Capecitabine—kidney cancer	8.4e-05	0.000431	CcSEcCtD
Mannitol—Urethral disorder—Doxorubicin—kidney cancer	8.38e-05	0.00043	CcSEcCtD
Mannitol—Asthenia—Paclitaxel—kidney cancer	8.24e-05	0.000423	CcSEcCtD
Mannitol—Decreased appetite—Capecitabine—kidney cancer	8.19e-05	0.000421	CcSEcCtD
Mannitol—Nausea—Gemcitabine—kidney cancer	8.14e-05	0.000418	CcSEcCtD
Mannitol—Gastrointestinal disorder—Capecitabine—kidney cancer	8.13e-05	0.000418	CcSEcCtD
Mannitol—Fatigue—Capecitabine—kidney cancer	8.12e-05	0.000417	CcSEcCtD
Mannitol—Pruritus—Paclitaxel—kidney cancer	8.12e-05	0.000417	CcSEcCtD
Mannitol—Pain—Capecitabine—kidney cancer	8.06e-05	0.000414	CcSEcCtD
Mannitol—Diarrhoea—Paclitaxel—kidney cancer	7.85e-05	0.000403	CcSEcCtD
Mannitol—Feeling abnormal—Capecitabine—kidney cancer	7.76e-05	0.000399	CcSEcCtD
Mannitol—Mediastinal disorder—Doxorubicin—kidney cancer	7.7e-05	0.000396	CcSEcCtD
Mannitol—Chills—Doxorubicin—kidney cancer	7.67e-05	0.000394	CcSEcCtD
Mannitol—Dizziness—Paclitaxel—kidney cancer	7.59e-05	0.00039	CcSEcCtD
Mannitol—Mental disorder—Doxorubicin—kidney cancer	7.49e-05	0.000385	CcSEcCtD
Mannitol—Urticaria—Capecitabine—kidney cancer	7.48e-05	0.000384	CcSEcCtD
Mannitol—Body temperature increased—Capecitabine—kidney cancer	7.45e-05	0.000382	CcSEcCtD
Mannitol—Malnutrition—Doxorubicin—kidney cancer	7.44e-05	0.000382	CcSEcCtD
Mannitol—Flatulence—Doxorubicin—kidney cancer	7.33e-05	0.000377	CcSEcCtD
Mannitol—Vomiting—Paclitaxel—kidney cancer	7.3e-05	0.000375	CcSEcCtD
Mannitol—Rash—Paclitaxel—kidney cancer	7.24e-05	0.000372	CcSEcCtD
Mannitol—Dermatitis—Paclitaxel—kidney cancer	7.23e-05	0.000371	CcSEcCtD
Mannitol—Nervousness—Doxorubicin—kidney cancer	7.23e-05	0.000371	CcSEcCtD
Mannitol—Back pain—Doxorubicin—kidney cancer	7.2e-05	0.00037	CcSEcCtD
Mannitol—Headache—Paclitaxel—kidney cancer	7.19e-05	0.000369	CcSEcCtD
Mannitol—Vision blurred—Doxorubicin—kidney cancer	7.01e-05	0.00036	CcSEcCtD
Mannitol—Hypersensitivity—Capecitabine—kidney cancer	6.94e-05	0.000356	CcSEcCtD
Mannitol—Ill-defined disorder—Doxorubicin—kidney cancer	6.9e-05	0.000355	CcSEcCtD
Mannitol—Nausea—Paclitaxel—kidney cancer	6.82e-05	0.00035	CcSEcCtD
Mannitol—Asthenia—Capecitabine—kidney cancer	6.76e-05	0.000347	CcSEcCtD
Mannitol—Malaise—Doxorubicin—kidney cancer	6.71e-05	0.000345	CcSEcCtD
Mannitol—Vertigo—Doxorubicin—kidney cancer	6.68e-05	0.000343	CcSEcCtD
Mannitol—Pruritus—Capecitabine—kidney cancer	6.67e-05	0.000342	CcSEcCtD
Mannitol—Cough—Doxorubicin—kidney cancer	6.49e-05	0.000333	CcSEcCtD
Mannitol—Convulsion—Doxorubicin—kidney cancer	6.45e-05	0.000331	CcSEcCtD
Mannitol—Diarrhoea—Capecitabine—kidney cancer	6.45e-05	0.000331	CcSEcCtD
Mannitol—Hypertension—Doxorubicin—kidney cancer	6.42e-05	0.00033	CcSEcCtD
Mannitol—Chest pain—Doxorubicin—kidney cancer	6.33e-05	0.000325	CcSEcCtD
Mannitol—Arthralgia—Doxorubicin—kidney cancer	6.33e-05	0.000325	CcSEcCtD
Mannitol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	6.29e-05	0.000323	CcSEcCtD
Mannitol—Discomfort—Doxorubicin—kidney cancer	6.26e-05	0.000321	CcSEcCtD
Mannitol—Dizziness—Capecitabine—kidney cancer	6.23e-05	0.00032	CcSEcCtD
Mannitol—Oedema—Doxorubicin—kidney cancer	6.07e-05	0.000312	CcSEcCtD
Mannitol—Infection—Doxorubicin—kidney cancer	6.03e-05	0.00031	CcSEcCtD
Mannitol—Vomiting—Capecitabine—kidney cancer	5.99e-05	0.000308	CcSEcCtD
Mannitol—Nervous system disorder—Doxorubicin—kidney cancer	5.96e-05	0.000306	CcSEcCtD
Mannitol—Rash—Capecitabine—kidney cancer	5.94e-05	0.000305	CcSEcCtD
Mannitol—Dermatitis—Capecitabine—kidney cancer	5.93e-05	0.000305	CcSEcCtD
Mannitol—Tachycardia—Doxorubicin—kidney cancer	5.93e-05	0.000304	CcSEcCtD
Mannitol—Headache—Capecitabine—kidney cancer	5.9e-05	0.000303	CcSEcCtD
Mannitol—Skin disorder—Doxorubicin—kidney cancer	5.9e-05	0.000303	CcSEcCtD
Mannitol—Hypotension—Doxorubicin—kidney cancer	5.67e-05	0.000291	CcSEcCtD
Mannitol—Nausea—Capecitabine—kidney cancer	5.6e-05	0.000287	CcSEcCtD
Mannitol—Musculoskeletal discomfort—Doxorubicin—kidney cancer	5.53e-05	0.000284	CcSEcCtD
Mannitol—Dyspnoea—Doxorubicin—kidney cancer	5.41e-05	0.000278	CcSEcCtD
Mannitol—Decreased appetite—Doxorubicin—kidney cancer	5.28e-05	0.000271	CcSEcCtD
Mannitol—Gastrointestinal disorder—Doxorubicin—kidney cancer	5.24e-05	0.000269	CcSEcCtD
Mannitol—Fatigue—Doxorubicin—kidney cancer	5.24e-05	0.000269	CcSEcCtD
Mannitol—Pain—Doxorubicin—kidney cancer	5.19e-05	0.000267	CcSEcCtD
Mannitol—Feeling abnormal—Doxorubicin—kidney cancer	5e-05	0.000257	CcSEcCtD
Mannitol—Urticaria—Doxorubicin—kidney cancer	4.82e-05	0.000248	CcSEcCtD
Mannitol—Body temperature increased—Doxorubicin—kidney cancer	4.8e-05	0.000247	CcSEcCtD
Mannitol—Hypersensitivity—Doxorubicin—kidney cancer	4.47e-05	0.00023	CcSEcCtD
Mannitol—Asthenia—Doxorubicin—kidney cancer	4.36e-05	0.000224	CcSEcCtD
Mannitol—Pruritus—Doxorubicin—kidney cancer	4.3e-05	0.000221	CcSEcCtD
Mannitol—Diarrhoea—Doxorubicin—kidney cancer	4.15e-05	0.000213	CcSEcCtD
Mannitol—Dizziness—Doxorubicin—kidney cancer	4.02e-05	0.000206	CcSEcCtD
Mannitol—Vomiting—Doxorubicin—kidney cancer	3.86e-05	0.000198	CcSEcCtD
Mannitol—Rash—Doxorubicin—kidney cancer	3.83e-05	0.000197	CcSEcCtD
Mannitol—Dermatitis—Doxorubicin—kidney cancer	3.83e-05	0.000196	CcSEcCtD
Mannitol—Headache—Doxorubicin—kidney cancer	3.8e-05	0.000195	CcSEcCtD
Mannitol—Nausea—Doxorubicin—kidney cancer	3.61e-05	0.000185	CcSEcCtD
